About Benten BioServices
Benten BioServices is a Healthcare company based in Malvern (United States) founded in 2008, and was acquired by Deltagen in December 2009. Biological safety testing and biomanufacturing services are offered for biopharmaceuticals. Benten BioServices has raised $8.1 million across 5 funding rounds from investors including LSG Investments, Penn Venture Partners and Deltagen. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its competitors include BioAgilytix, Advion and Evans Analytical Group; 1 of its 3 listed competitors has raised funding.
Company details
Benten BioServices was founded in 2008 and operates as a contract services organization in the biotechnology and pharmaceutical sectors. Regulatory-compliant manufacturing and testing services are provided to support biopharmaceutical development and commercialization. These include biosafety and raw materials testing, assay and process validation, cell banking and characterization, filling and packaging, as well as pre-clinical development, CRO support, and RD consulting. The company is based in Malvern, United States.
- Headquarters Malvern, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website bentenbio.com
- Acquired by Deltagen (Dec 2009)
- Total Equity Funding$8.1M (USD)
in 5 rounds
- Latest Funding Round$78.5K (USD), Debt – Conventional
May 2013
- InvestorsLSG Investments
& 2 more
- Acquired byDeltagen
(Dec 2009)
Funding Insights of Benten BioServices
Benten BioServices has successfully raised a total of $8.1M across 5 strategic funding rounds. The most recent funding activity was a Debt β Conventional round of $78.5 thousand completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.1M
- Total Rounds 5
- Last Round Debt – Conventional β $78,500
- First Round $2.74M
(Dec 2011)
- Investors Count 2
All 5 funding rounds of Benten BioServices with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2013 | $78,500 | Debt – Conventional | β | β | β |
| Jan 2013 | $1.32M | Series A | β | β | |
| Oct 2012 | $1.1M | Series A | β | β | β |
| Aug 2012 | $2.94M | Series A | β | LSGPA, Penn Venture Partners | β |
| Dec 2011 | $2.74M | Seed | β | β | β |
3 investors in total: 3 institutional.
Investors in Benten BioServices
Benten BioServices has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include LSG Investments, Penn Venture Partners and Deltagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in life sciences technologies. | lsgpa.com | Harrisburg, United States | ||
| pennventures.com | ||||
Provides drug discovery tools and services to the biopharmaceutical industry. | 1997 | deltagen.com | San Mateo, United States |
Investor details for Benten BioServices
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Benten BioServices
4 dated milestones of Benten BioServices across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Benten BioServices is founded.
- Exit Acquired by Deltagen.
- Funding First funding round of $2.7M.
- Funding Latest funding round, Debt β Conventional, of $78K.
Competitors of Benten BioServices
Benten BioServices has 3 listed competitors in our database, 1 of them funded. They include BioAgilytix, Advion and Evans Analytical Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioagilytix.com | 2008 | Durham, United States | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | ||
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| eag.com | 1978 | San Diego, United States | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries |
Detailed competitors of Benten BioServices
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Benten BioServices (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Benten BioServices
Benten BioServices was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Benten BioServices is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
Benten BioServices is a funded company, having raised a total of $8.1M across 5 funding rounds to date. The company's 1st funding round was a Seed of $2.74M, raised on Dec 2011.
Benten BioServices was founded in 2008 and operates as a contract services organization in the biotechnology and pharmaceutical sectors. Regulatory-compliant manufacturing and testing services are provided to support biopharmaceutical development and commercialization. These include biosafety and raw materials testing, assay and process validation, cell banking and characterization, filling and packaging, as well as pre-clinical development, CRO support, and RD consulting. The company is based in Malvern, United States.
Benten BioServices's top competitors include BioAgilytix, Advion and Evans Analytical Group.
Benten BioServices has 3 investors. Key investors include LSG Investments, Penn Venture Partners, and Deltagen.
Yes. Benten BioServices was acquired by Deltagen in December 2009.
